Skip to main content
Livermore
Livermore
ZHEN

State Street Corp

SEC CIK
0000093751
Latest filing
Sep 22, 2026

AKRO holding history

Akero Therapeutics, Inc. in every 13F filed by State Street Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AKRO overviewAll 13F holders of AKROFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of AKRO by State Street Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−3,414,306−100.0%Sold outHolders
Q3 20253,414,306$162.1M<0.1%+668,742+24.4%AddedHolders
Q2 20252,745,564$146.5M<0.1%+250,821+10.1%AddedHolders
Q1 20252,494,743$101.0M<0.1%+158,799+6.8%AddedHolders
Q4 20242,335,944$65.0M<0.1%−167,002−6.7%ReducedHolders
Q3 20242,502,946$71.8M<0.1%−186,480−6.9%ReducedHolders
Q2 20242,689,426$63.1M<0.1%−1,108,304−29.2%ReducedHolders
Q1 20243,797,730$95.9M<0.1%−1,325,165−25.9%ReducedHolders
Q4 20235,122,895$119.6M<0.1%+2,617,047+104.4%AddedHolders
Q3 20232,505,848$126.7M<0.1%+265,617+11.9%AddedHolders
Q2 20232,240,231$104.6M<0.1%+9,424+0.4%AddedHolders
Q1 20232,230,807$85.4M<0.1%−270,162−10.8%ReducedHolders
Q4 20222,500,969$137.1M<0.1%+1,953,347+356.7%AddedHolders
Q3 2022547,622$18.6M<0.1%+54,770+11.1%AddedHolders
Q2 2022492,852$4.66M<0.1%−746,265−60.2%ReducedHolders
Q1 20221,239,117$17.6M<0.1%+206,496+20.0%AddedHolders
Q4 20211,032,621$21.8M<0.1%−121,480−10.5%ReducedHolders
Q3 20211,154,101$25.8M<0.1%−75,039−6.1%ReducedHolders
Q2 20211,229,140$30.5M<0.1%+289,094+30.8%AddedHolders
Q1 2021940,046$27.3M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.